Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ipratropium bromide 20micrograms/dose inhaler CFC free
0301020I0AAANAN
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | 38,237 |
|
Ipratropium bromide 500micrograms/2ml neb liq ud vials
0301020I0AAACAC
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | 13,408 |
|
Ipratropium bromide 250micrograms/1ml neb liq ud vials
0301020I0AAAFAF
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | 5,427 |
|
Ipratropium bromide 20micrograms/dose BA inhaler
0301020I0AAAGAG
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 20micrograms/dose inhaler
0301020I0AAAAAA
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 40microgram inhalation pdr caps with dev
0301020I0AAAHAH
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 40microgram inhalation powder capsules
0301020I0AAAIAI
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
|
Ipratropium bromide 40micrograms/dose inhaler
0301020I0AAADAD
|
Ipratropium bromide (Bronchodilators) | Ipratropium bromide | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.